Ambiguous Genitalia

Pediatric Endocrinology

Volumn , Issue , 2008, Pages 127-164

  Witchel, Selma F ^a   Lee, Peter A ^b,c,d,e  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

^c PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e RILEY HOSPITAL FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882498544     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-141604090-3.50009-0     Document Type: Chapter

References (409)

1. Lee PA, Houk CP, Ahmed SF, Hughes IA, the International Consensus Conference on Intersex Working Group Consensus statement on management of intersex disorders. Pediatrics 2006, 118:e488--500.
2. Vilain E, Achermann JC, Eugster EA, Harley VR, Morel Y, Wilson JD, et al. We used to call them hermaphrodites. Genetics in Medicine 2007, 9:65.
3. Kim Y, Capel B Balancing the bipotential gonad between alternative organ fates: A new perspective on an old problem. Dev Dynamics 2006, 235:2292.
4. Jost A Recherches sur la différenciation sexuelle de l'embryon del lapin. Arch Anat Microsc Morph Exp 1947, 36:271.
5. Sinclair AH, Berta P, Palmer MS, Hawkins JR, Griffiths BL, Smith MJ, et al. A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motif. Nature 1990, 346(6281):240.
6. Gubbay J, Collignon J, Koopman P, Capel B, Economou A, Munsterberg A, et al. A gene mapping to the sex-determining region of the mouse Y chromosome is a member of a novel family of embryonically expressed genes. Nature 1990, 346(6281):245.
7. Park SY, Jameson JL Transcriptional regulation of gonadal development and differentiation. Endocrinology 1993, 146:1035.
8. Wylie CC The biology of primordial germ cells. Eur Urol 1993, 23:62.
9. Parker KL, Schimmer BP Embryology and Genetics of the Mummalian Gonads and Ducts. Knobil and Neill's Physiology of Reproduction 2006, 313-336. Elsevier, St. Louis. 3/e.
10. Capel B Sex in the 90s: SRY and the switch to the male pathway. Annu Rev Physiol 1998, 60:497.
11. Bullejos M, Koopman P Delayed Sry and Sox9 expression in developing mouse gonads underlies B6-Y(DOM) sex reversal. Dev Biol 2005, 278(2):473.
12. De Santa Barbara P, Moniot B, Poulat F, et al. Expression and subcellular localization of SF-1, SOX9, WT1, and AMH proteins during early human testicular development. Dev Dyn 2000, 217:293.
13. Capel B, Albrecht KH, Washburn LL, Eicher EM Migration of mesonephric cells into the mammalian gonad depends on Sry. Mech Dev 1999, 84:127.
14. Schmahl J, Eicher E, Washburn L, Capel B Sry induces cell proliferation in the mouse gonad. Development 2000, 127:65.
15. Wilhelm D, Hiramatsu R, Mizusaki H, Widjaja L, Combes AN, Kanai Y, et al. SOX9 regulates prostaglandin D synthase gene transcription in vivo to ensure testis development. Journal of Biological Chemistry 2007, 282:10553.
16. Wilhelm D, Martinson F, Bradford S, Wilson MJ, Combes AN, Beverdam A, et al. Sertoli cell differentiation is induced both cell-autonomously and through prostaglandin signaling during mammalian sex determination. Dev Biol 2005, 287:111.
17. Malki S, et al. Prostaglandin D2 induces nuclear. EMBO J 2005, 24:1798.
18. Kim Y, Kobayashi A, Sekido R, DiNapoli L, Brennan J, Chaboissier MC, et al. Fgf9 and Wnt4 act as antagonistic signals to regulate mammalian sex determination. PLoS Biol 2006, 4:1000.
19. Wilhelm D, Koopman P The makings of maleness: Towards an integrated view of male sexual development. Nature Review Genetics 2006, 7:620.
20. Jeanes A, Wilhelm D, Wilson MJ, Bowles J, McClive PJ, Sinclair AH, et al. Evaluation of candidate markers for the peritubular myoid cell lineage in the developing mouse testis. Reproduction 2005, 130:509.
21. Clark AM, Garland KK, Russell LD Desert hedgehog (Dhh) gene is required in the mouse testis for formation of adult-type Leydig cells and normal development of peritubular cells and seminiferous tubules. Biology of Reproduction 2000, 63:1825.
22. Zondek LH, Zondek T Ovarian hilar cells and testicular Leydig cells in anencephaly. Biol Neonate 1983, 43:211.
23. Wilhelm D, Palmer S, Koopman P Sex determination and gonadal development in mammals. Physiol Rev 2007, 87:1.
24. Nef S, Schaad O, Stallings NR, Cederroth CR, Pitetti JL, Schaer G, et al. Gene expression during sex determination reveals a robust female genetic program at the onset of ovarian development. Dev Biol 2005, 287:361.
25. Tanaka SS, Yamaguchi YL, Tsoi B, Lickert H, Tam PP IFITM/Mil/fragilis family proteins IFITM1 and IFITM3 play distinct roles in mouse primordial germ cell homing and repulsion. Dev Cell 2005, 9:745.
26. Molyneaux KA, Zinszner H, Kunwar PS, Schaible K, Stebler J, Sunshine MJ, et al. The chemokine SDF1/CXCL12 and its receptor CXCR4 regulate mouse germ cell migration and survival. Development 2003, 130:4279.
27. Kimble J, Page DC The mysteries of sexual identity. The germ cell's perspective. Science 2007, 316:400.
28. Bowles J, Knight D, Smith C, Wilhelm D, Richman J, Mamiya S, et al. Retinoid signaling determines germ cell fate in mice. Science 2006, 312:596.
29. Baltus AE, Menke DB, Hu YC, Goodheart ML, Carpenter AE, de Rooij DG, et al. In germ cells of mouse embryonic ovaries, the decision to enter meiosis precedes premeiotic DNA replication. Nature Genetics 2006, 38:1430.
30. Baker TG A quantitative and cytological study of germ cells in human ovaries. Proc R Soc Med Lond 1963, 158:417.
31. Koubova J, Menke DB, Zhou Q, Capel B, Griswold MD, Page DC Retinoic acid regulates sex-specific timing of meiotic initiation in mice. Proceeding of the National Academy of Science USA 2006, 103:2474.
32. McLaren A, Southee D Entry of mouse embryonic germ cells into meiosis. Dev Biol 1997, 187:107.
33. Schaefer CB, Ooi SK, Bestor TH, Bourc'his D Epigenetic decisions in mammalian germ cells. Science 2007, 316:398.
34. Allegrucci C, Thurston A, Lucas E, Young L Epigenetics and the germline. Reproduction 2005, 129:137.
35. Münsterberg A, Lovell-Badge R Expression of the mouse anti-Müllerian hormone gene suggests a role in both male and female sexual differentiation. Development 1991, 113:613.
36. Roberts LM, Visser JA, Ingraham HA Involvement of a matrix metalloproteinase in MIS-induced cell death during urogenital development. Development 2002, 129:1487.
37. Zhan Y, Fujino A, MacLaughlin DT, Manganaro TF, Szotek PP, Arango NA, et al. Mullerian inhibiting substance regulates its receptor/SMAD signaling and causes mesenchymal transition of the coelomic epithelial cells early in Mullerian duct regression. Development 2006, 133:2359.
38. Catlin EA, MacLaughlin DT, Donahoe PK Müllerian inhibiting hormone substance: new perspectives and future directions. Microscopy Res Technique 1993, 25:121.
39. Vigier B, Watrin F, Magre S, et al. Purified bovine AMH induces a characteristic freemartin effect in fetal rat prospective ovaries exposed to it in vitro. Development 1987, 100:43.
40. Vigier B, Forest MG, Eychenne B, et al. Anti-Müllerian hormone produces endocrine sex-reversal of fetal ovaries. Proc Natl Acad Sci 1989, 86:3684.
41. Marker PC, Donjacour AA, Dahiya R, Cunha GR Hormonal, cellular, and molecular control of prostatic development. Dev Biol 2003, 253:156.
42. Zhang TJ, Hoffman BG, Ruiz de Algara T, Helgason CD SAGE reveals expression of Wnt signalling pathway members during mouse prostate development. Gene Expr Patterns 2006, 6:310.
43. Clarnette TD, Sugita Y, Hutson JM Genital anomalies in human and animal models reveal the mechanisms and hormones governing testicular descent. Br J Urol 1997, 79:99.
44. Goto M, Piper Hanley K, Marcos J, Wood PJ, Wright S, Postle AD, et al. In humans, early cortisol biosynthesis provides a mechanism to safeguard female sexual development. J Clin Invest 2006, 116:953.
45. White PC Ontogeny of adrenal steroid biosynthesis: why girls will be girls. J Clin Invest 2006, 116:872.
46. Grumbach MM, Auchus RJ Estrogen: Consequences and implications of human mutations in synthesis and action. J Clin Endocrinol Metab 1999, 84:4677.
47. Wilson JD Androgens, androgen receptors, and male gender role behavior. Horm Behav 2001, 40:358.
48. Arnold AP, Burgoyne PS Are XX and XY brain cells intrinsically different?. Trends Endocrinol Metab 2004, 15:6.
49. de Courten-Myers GM The human cerebral cortex: Gender differences in structure and function. J Neuropathol Exp Neurol 1999, 58:217.
50. Rabinowicz T, Dean DE, Petetot JM, de Courten-Myers GM Gender differences in the human cerebral cortex: more neurons in males: More processes in females. J Child Neurol 1999, 14:98.
51. Swain A, Lovell-Badge R Mammalian sex determination: A molecular drama. Genes Dev 1999, 13:755.
52. Koopman P, Gubbay J, Vivian N, et al. Male development of chromosomally female mice transgenic for Sry. Nature 1991, 351:117.
53. Hacker A, Capel B, Goodfellow P, et al. Expression of Sry, the mouse sex determining gene. Development 1995, 121:1603.
54. Kreidberg JA, Sariola H, Loring JM, et al. WT-1 is required for early kidney development. Cell 1993, 74:679.
55. Ikeda Y, Shen W-H, Ingraham HA, et al. Developmental expression of mouse steroidogenic factor-1, an essential regulator of the steroid hydroxylases. Mol Endocrinol 1994, 8:654.
56. Parker KL, Schimmer BP Steroidogenic factor 1: a key determinant of endocrine development and function. Endocr Rev 1997, 18:361.
57. Luo X, Ikeda Y, Schlosser DA, et al. Steroidogenic factor 1 is the essential transcript encoded by the mouse Ftz-F1 gene. Mol Endocrinol 1995, 9:1233.
58. Zhao L, Bakke M, Hanley NA, Majdic G, Stallings NR, Jeyasuria P, et al. Tissue-specific knockouts of steroidogenic factor 1. Mol Cell Endocrinol 2004, 215:89.
59. Vidal VP, Chaboissier MC, de Rooij DG, Schedl A Sox9 induces testis development in XX transgenic mice. Nat Genet 2001, 28:216.
60. Chaboissier MC, Kobayashi A, Vidal VIP, Lützkendorf S, van de Kant HJK, Wegner M, et al. Functional analysis of Sox8 and Sox9 during sex determination in the mouse. Development 2004, 131:1891.
61. Bi W, Deng JM, Zhang Z, et al. Sox9 is required for cartilage formation. Nat Genet 1999, 22:85.
62. Miyamoto N, Yoshida M, Kuratani S, et al. Defects of urogenital development in mice lacking Emx2. Development 1997, 124:1653.
63. Pellegrini M, Pantano S, Lucchini F, et al. Emx2 developmental expression in primorida of the reproductive and excretory systems. Anat Embryol 1997, 196:427.
64. Fujii T, Pichel JG, Taira M, et al. Expression patterns of the murine LIM class homeobox gene Lim1in the developing brain and excretory system. Developmental Dynamics 1994, 199:73.
65. Shawlot W, Behringer RR Requirement for Lim1 in head-organizer function. Nature 1995, 374:425.
66. Swain A, Zanaria E, Hacker A, et al. Mouse Dax-1 expression is consistent with a role in sex determination as well as in adrenal and hypothalamus function. Nat Genet 1996, 12:404.
67. Ito M, Yu R, Jameson JL DAX-1 inhibits SF-1 mediated transactivation via a carboxy-terminal domain that is deleted in adrenal hypoplasia congenita. Mol Cell Biol 1997, 17:1476.
68. Zazopoulos E, Lalli E, Stocco DM, et al. DNA binding and transcriptional repression by DAX-1 blocks steroidogenesis. Nature 1997, 390:311.
69. Crawford PA, Dorn C, Sadovsky Y, et al. Nuclear receptor DAX-1 recruits nuclear receptor corepressor N-CoR to steroidogenic factor 1. Mol Cell Biol 1998, 18:2949.
70. Hanley NA, Rainey WE, Wilson DI, et al. Expression profiles of SF-1, DAX1, and CYP17 in the human fetal adrenal gland: Potential interactions in gene regulation. Mol Endocrinol 2001, 15:57.
71. Yu RN, Ito M, Saunders TL, et al. Role of Ahch in gonadal development and gametogenesis. Nat Genet 1998, 20:353.
72. Swain A, Narvaez V, Burgoyne P, Camerino G, Lovell-Badge R Dax1 antagonizes Sry action in mammalian sex determination. Nature 1998, 391:761.
73. DiNapoli L, Batchvarov J, Capel B FGF9 promotes survival of germ cells in the fetal testis. Development 2006, 133:1519.
74. Vainio S, Heikkila M, Kispert A, et al. Female development in mammals is regulated by Wnt-4 signalling. Nature 1999, 397:405.
75. Jeays-Ward K, Hoyle C, Brennan J, Dandonneau M, Alldus G, Capel B, et al. Endothelial and steroidogenic cell migration are regulated by WNT4 in the developing mammalian gonad. Development 2003, 130:3663.
76. Parr BA, McMahon AP Sexually dimorphic development of the mammalian reproductive tract requires Wnt-7a. Nature 1998, 395:707.
77. Besmer P, Manova K, Duttlinger R, Huang EJ, Packer A, Gyssler C, et al. The kit-ligand (steel factor) and its receptor c-kit/W: pleiotropic roles in gametogenesis and melanogenesis. Dev 1993, 125. [volume].
78. Brannan CI, Lyman SD, Williams DE, et al. Steel-Dickie mutation encodes a c-kit ligand lacking transmembrane and cytoplasmic domains. Proc Nat Acad Sci 1991, 88:4671.
79. Haqq CM, King CY, Ukiyama E, et al. Molecular basis of mammalian sexual determination: Activation of Müllerian inhibiting substance gene expression by SRY. Science 1994, 266:1494.
80. Shen WH, Moore CCD, Ikeda Y, et al. Nuclear receptor steroidogenic factor 1 regulates the Müllerian inhibiting substance gene: A link to the sex determination cascade. Cell 1994, 77:651.
81. de Santa Barbara P, Bonneaud N, Boizet B, et al. Direct interaction of SRY-related protein SOX9 and steroidogenic factor1 regulates transcription of the human anti-Müllerian hormone gene. Mol Cell Biol 1998, 18:6653.
82. Arango NA, Lovell-Badge R, Behringer RR Targeted mutagenesis of the endogenous mouse Mis gene promoter: In vivo definition of genetic pathways of vertebrate sexual development. Cell 1999, 99:409.
83. Kamachi Y, Uchikawa M, Kondoh H Pairing SOX off with partners in the regulation of embryonic development. Trends Genet 2000, 16:182.
84. de Santa Barbara P, Moniot B, Poulat F, et al. Steroidogenic factor-1 regulates transcription of the human anti-müllerian hormone receptor. J Biol Chem 1998, 273:29654.
85. Bitgood MJ, Shen L, McMahon AP Sertoli cell signaling by desert hedgehog regulates the male germline. Curr Biol 1996, 6:298.
86. Parmantier E, Lynn B, Lawson D, et al. Schwann cell-derived desert hedgehog controls the development of peripheral nerve sheath. Neuron 1999, 23:713.
87. Bitgood MJ, McMahon AP Hedgehog and Bmp genes are coexpressed at many diverse sites of cell-cell interaction in the mouse embryo. Dev Biol 1995, 172:126.
88. Zimmermann S, Steding G, Emmen JMA, et al. Targeted disruption of the Insl3 gene causes bilateral cryptorchidism. Mol Endocrinol 1999, 13:681.
89. Nef S, Parada L Cryptorchidism in mice mutant for Insl3. Nature Genetics 1999, 22:295.
90. Rijli FM, Matyas R, Pellegrini M, et al. Cryptorchidism and homeotic transformations of spinal nerves and vertebrae in Hoxa-10 mutant mice. Proc Natl Acad Sci 1995, 92:8185.
91. Gorlov IP, Kamat A, Bogatcheva NV, Jones E, Lamb DJ, Truong A, et al. Mutations of the GREAT gene cause cryptorchidism. Hum Mol Genet 2002, 11:2309.
92. Barbaux S, Niaudet P, Gubler M-C, et al. Donor splice-site mutations in WT1 are responsible for Frasier syndrome. Nature Genetics 1997, 17:467.
93. Varanasi R, Bardeesy N, Ghahremani M, et al. Fine structure analysis of the WT1 gene in sporadic Wilms tumors. Proc Natl Acad Sci 1994, 91:3554.
94. Denys P, Malvaux P, van den Berghe H, et al. Association d'un syndrome anatomo-pathologique de pseudohermaphroditisme masculin d'une tumeur de Wilms, d'une nephropathieparenchymateuse et d'un mosaicisme XX/XY. Arch Fr Pediatr 1967, 24:729.
95. Drash A, Sherman F, Hartmann WH, et al. A syndrome of pseudohermaphroditism, Wilms' tumor, hypertension, and degenerative renal disease. J Pediatr 1979, 76:585.
96. Jadresic L, Leake J, Gordon I, et al. Clinicopathologic review of twelve children with nephropathy, Wilms' tumor, and genital abnormalities (Drash syndrome). J Pediatr 1990, 117:717.
97. Schmitt K, Zabel B, Tulzer G, et al. Nephropathy with Wilms tumour or gonadal dysgenesis: Incomplete Denys-Drash syndrome or separate diseases?. European Journal of Pediatrics 1995, 154:577.
98. Bardeesy N, Zabel B, Schmitt K, et al. WT1 mutations associated with incomplete Denys-Drash syndrome define a domain predicted to behave in a dominant-negative fashion. Genomics 1994, 21:663.
99. Barbosa AS, Hadjuatgabasiou CG, Theodoridis C, et al. The same mutation affecting the splicing of WT1 gene is present on Frasier syndrome patients with or without Wilms' tumor. Hum Mutat 1999, 13:146.
100. Davies JA, Ladomery M, Hohenstein P, Michael L, Shafe A, Spraggon L, et al. Development of an siRNA-based method for repressing specific genes in renal organ culture and its use to show that the Wt1 tumour suppressor is required for nephron differentiation. Hum Mol Genet 2004, 13:235.
101. Klattig J, Sierig R, Kruspe D, Besenbeck B, Englert C The Wilms tumor protein Wt1 is an activator of the anti-Mullerian hormone receptor gene Amhr2. Mol Cell Biol 2007, 27:4355.
102. Larsson SH, Charlieu J-P, Miyagawa K, et al. Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternative splicing. Cell 1995, 81:391.
103. Yao HH, Matzuk MM, Jorgez CJ, Menke DB, Page DC, Swain A, et al. Follistatin operates downstream of Wnt4 in mammalian ovary organogenesis. Dev Dyn 2004, 230:210.
104. Elejalde BR, Opitz JM, de Elejalde MM, Gilbert EF, Abellera M, Meisner L, et al. Tandem dup (1p) within the short arm of chromosome 1 in a child with ambiguous genitalia and multiple congenital anomalies. Am J Med Genet 1984, 17:723.
105. Biason-Lauber A, De Filippo G, Konrad D, Scarano G, Nazzaro A, Schoenle EJ WNT4 deficiency: A clinical phenotype distinct from the classic Mayer-Rokitansky-Kuster-Hauser syndrome, A case report. Hum Reprod 2007, 22:224.
106. Biason-Lauber A, Konrad D, Navratil F, Schoenle EJ A WNT4 mutation associated with Mullerian-duct regression and virilization in a 46,XX woman. N Engl J Med 2004, 351:792.
107. Fleming A, Vilain E The endless quest for sex determination genes. Clin Genet 2004, 67:15.
108. Harley VR, Clarkson MJ, Argentaro A The molecular action and regulation of the testis-determining factors, SRY (sex-determining region on the Y chromosome) and SOX9 [SRY-related high-mobility group (HMG) box 9]. Endocr Rev 2003, 24:466.
109. Schnitt-Ney M, Thiele H, Kaltwasser P, et al. Two novel SRY missense mutations reducing DNA binding identified in XY females and their mosaic father. Am J Hum Genet 1995, 56:862.
110. Hines RS, Tho SP, Zhang YY, et al. Paternal somatic and germ-line mosaicism for a sex-determining region on Y (SRY) missense mutation leading to recurrent 46,XY sex reversal. Fertil Steril 1997, 67:675.
111. Hawkins JR, Taylor A, Goodfellow PN, et al. Evidence for increased prevalence of SRY mutations in XY females with complete rather than partial gonadal dysgenesis. Am J Hum Genet 1992, 51:979.
112. Jager RJ, Harley VR, Pfeiffer RA, et al. A familial mutation in the testis-determining gene SRY shared by both sexes. Hum Genet 1992, 90:350.
113. Telvi L, Lebbar A, Del Pino O, et al. 45,X/46,XY mosaicism: Report of 27 cases. Pediatrics 1999, 104(2/1):304.
114. Mendez JP, Ulloa-Aguirre A, Kofman-Alfaro S, et al. Mixed gonadal dysgenesis: Clinical, cytogenetic, endocrinological, and histopathological findings in 16 patients. Am J Med Genet 1993, 46:263.
115. Lukusa T, Fryns JP, Kleczkowska A, et al. Role of gonadal dysgenesis in gonadoblastoma induction in 46, XY individuals. The Leuven experience in 46, XY pure gonadal dysgenesis and testicular feminization syndromes. Genet Couns 1991, 2:9.
116. Iezzoni JC, Von Kap-Herr C, Golden WL, et al. Gonadoblastomas in 45,X/46,XY mosaicism: Analysis of Y chromosome distribution by fluorescence in situ hybridization. Am J Clin Pathol 1997, 108:197.
117. Alikasifoglu A, Kandemir N, Caglar M, et al. Prepubertal gonadoblastoma in a 46,XY female patient with features of Turner syndrome. Eur J Pediatr 1996, 155:653.
118. Foster JW, Dominguez-Steglich MA, Guioli S, et al. Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene. Nature 1994, 372:525.
119. Wagner T, Wirth J, Meyer J, et al. Autosomal sex reversal and campomelic dwarfism are caused by mutations in and around the SRY-related gene SOX9. Cell 1994, 79:1111.
120. Meyer J, Sudbeck P, Held M, et al. Mutational analysis of the SOX9 gene in campomelic dysplasia and autosomal sex reversal: lack of genotype/phenotype correlations. Hum Molec Genet 1997, 6:91.
121. Cameron FJ, Hageman RM, Cooke-Yarborough C, et al. A novel germ line mutation in SOX9 causes familial campomelic dysplasia and sex reversal. Hum Molec Genet 1996, 5:1625.
122. Tommerup N, Schempp W, Meinecke P, et al. Assignment of an autosomal sex reversal locus (SRA1) and campomelic dysplasia (CMPD1) to 17q24.3-q25.1. Nature Genet 1993, 4:170.
123. Preiss S, Argentaro A, Clayton A, John A, Jans DA, Ogata T, et al. Compound effects of point mutations causing campomelic dysplasia/autosomal sex reversal upon SOX9 structure, nuclear transport, DNA binding, and transcriptional activation. J Biol Chem 2001, 276:27864.
124. Pfeifer D, Kist R, Dewar K, et al. Campomelic dysplasia translocation breakpoints are scattered over 1 Mb proximal to SOX9: evidence for an extended control region. Am J Hum Genet 1999, 65:111.
125. Pop R, Zaragoza MV, Gaudette M, Dohrmann U, Scherer G A homozygous nonsense mutation in SOX9 in the dominant disorder campomelic dysplasia: a case of mitotic gene conversion. Hum Genet 2005, 117:43.
126. Bardoni B, Zanaria E, Guioli S, et al. A dosage sensitive locus at chromosome Xp21 is involved in male to female sex reversal. Nature Genetics 1994, 7:497.
127. Barbaro M, Oscarson M, Schoumans J, Staaf J, Ivarsson SA, Wedell A Isolated 46,XY gonadal dysgenesis in two sisters caused by a Xp21.2 interstitial duplication containing the DAX1 gene. J Clin Endocrinol Metab 2007, [E-pub ahead of print].
128. Bernard P, Ludbrook L, Queipo G, Dinulos MB, Kletter GB, Zhang YH, et al. A familial missense mutation in the hinge region of DAX1 associated with late-onset AHC in a prepubertal female. Mol Genet Metab 2006, 88:272.
129. Peter M, Viemann M, Partsch C-J, et al. Congenital adrenal hyperplasia: Clinical spectrum, experience with hormonal diagnosis, and report on new point mutations of the DAX-1 gene. J Clin Endocrinol Metab 1998, 83:2666.
130. Habiby RL, Boepple P, Nachtigall L, et al. Adrenal hypoplasia congenita with hypogonadotropic hypogonadism. Evidence that DAX-1 mutations lead to combined hypothalamic and pituitary defects in gonadotropin production. J Clin Invest 1996, 98:1055.
131. Seminara SB, Achermann JC, Genel M, et al. X-linked adrenal hypoplasia congenita: a mutation in DAX1 expands the phenotypic spectrum in males and females. J Clin Endocrinol Metab 1999, 84:4501.
132. Merke DP, Tajima T, Baron J, et al. Brief report: Hypogonadotropic hypogonadism in a female caused by an X-linked recessive mutation in the DAX1 gene. N Engl J Med 1999, 340:1248.
133. Francke U, Harper JF, Darras BT, et al. Congenital adrenal hypoplasia, myopathy, and glycerol kinase deficiency: molecular genetic evidence for deletions. Am J Hum Genet 1987, 40:212.
134. Muscatelli F, Strom TM, Walker AP, et al. Mutations in the DAX-1 gene give rise to both X-linked adrenal hypoplasia congenital and hypogonadotropic hypogonadism. Nature 1994, 372:672.
135. Reutens AT, Achermann JC, Ito M, et al. Clinical and functional effects of mutations in the DAX-1 gene in patients with adrenal hypoplasia congenita. J Clin Endocrinol Metab 1999, 84:504.
136. Bernard P, Ludbrook L, Queipo G, Dinulos MB, Kletter GB, Zhang YH, et al. A familial missense mutation in the hinge region of DAX1 associated with late-onset AHC in a prepubertal female. Mol Genet Metab 2006, 88:272.
137. Ho J, Zhang YH, Huang BL, McCabe ER NR0B1A: An alternatively spliced form of NR0B1. Mol Genet Metab 2004, 83:330.
138. Hossain A, Li C, Saunders GF Generation of two distinct functional isoforms of dosage-sensitive sex reversal-adrenal hypoplasia congenita-critical region on the X chromosome gene 1 (DAX-1) by alternative splicing. Mol Endocrinol 2004, 18:1428.
139. Bavner A, Sanyal S, Gustafsson JA, Treuter E Transcriptional corepression by SHP: Molecular mechanisms and physiological consequences. Trends Endocrinol Metab 2005, 16:478.
140. Altincicek B, Tenbaum SP, Dressel U, Thormeyer D, Renkawitz R, Baniahmad A Interaction of the corepressor Alien with DAX-1 is abrogated by mutations of DAX-1 involved in adrenal hypoplasia congenita. J Biol Chem 2000, 275:7662.
141. Iyer AK, Zhang YH, McCabe ER Dosage-sensitive sex reversal adrenal hypoplasia congenita critical region on the X chromosome, gene 1 (DAX1) (NR0B1) and small heterodimer partner (SHP) (NR0B2) form homodimers individually, as well as DAX1-SHP heterodimers. Mol Endocrinol 2006, 20:2326.
142. Umehara F, Tate G, Itoh K, et al. A novel mutation of desert hedgehog in a patient with 46,XY partial gonadal dysgenesis accompanied by minifascicular neuropathy. Am J Hum Genet 2000, 67:1302.
143. Canto P, Vilchis F, Soderlund D, Reyes E, Mendez JP A heterozygous mutation in the desert hedgehog gene in patients with mixed gonadal dysgenesis. Mol Hum Reprod 2005, 11:833.
144. Canto P, Soderlund D, Reyes E, Mendez JP Mutations in the desert hedgehog (DHH) gene in patients with 46,XY complete pure gonadal dysgenesis. J Clin Endocrinol Metab 2004, 89:4480.
145. Tate G, Satoh H, Endo Y, Mitsuya T Assignment of desert hedgehog (DHH) to human chromosome bands 12q12- -q13.1 by in situ hybridization. Cytogenet Cell Genet 2000, 88:93.
146. Muroya K, Okuyama T, Goishi K, et al. Sex-determining gene(s) on distal 9p: Clinical and molecular studies in six cases. J Clin Endocrinol Metab 2000, 85:3094.
147. Hoo JJ, Fischer A, Fuhrmann W Familial tiny 9p/20p translocation: 9p24. The critical segment for monosomy 9p syndrome. Ann Genet 1982, 25:249.
148. Huret JL, Leonard C, Forestier B, et al. Eleven new cases of del(9p) and features from 80 cases. J Med Genet 1988, 25:741.
149. Bennett CP, Docherty Z, Robb SA, et al. Deletion 9p and sex reversal. J Med Genet 1993, 30:518.
150. Ogata T, Muroya K, Matsuo N, et al. Impaired male sex development in an infant with molecularly defined partial 9p monosomy: implication for a testis forming gene(s) on 9p. J Med Genet 1997, 34:331.
151. McDonald MT, Flejter W, Sheldon S, et al. XY sex reversal and gonadal dysgenesis due to 9p24 monosomy. Am J Med Genet 1997, 73:321.
152. Burtis KC, Baker BS Drosophila doublesex gene controls somatic sexual differentiation by producing alternatively spliced mRNAs encoding sex-specific polypeptides. Cell 1989, 56:997.
153. Raymond CS, Parker ED, Kettlewell JR, et al. A region of human chromosome 9p required for testis development contains two genes related to known sexual regulators. Hum Mol Genet 1999, 8:989.
154. Ottolenghi C, Veitia R, Barbieri M, et al. The human doublesex-related gene, DMRT2, is homologous to a gene involved in somitogeneis and encodes a potential bicistronic transcript. Genomics 2000, 64:179.
155. Calvari V, Bertini V, De Grandi A, et al. A new submicroscopic deletion that refines the 9p region for sex reversal. Genomics 2000, 65:203.
156. Smith CA, McClive PJ, Western PS, et al. Conservation of a sex-determining gene. Nature 1999, 402:601.
157. De Grandi A, Calvari V, Bertini V, et al. The expression pattern of a mouse doublesex-related gene is consistent with a role in gonadal differentiation. Mech Dev 2000, 90:323.
158. Moniot B, Berta P, Scherer G, et al. Male specific expression suggests role of DMRT1 in human sex determination. Mech Dev 2000, 91:323.
159. Bartsch O, Kress W, Wagner A, et al. The novel contiguous gene syndrome of myotubular myopathy (MTM1), male hypogenitalism and deletion in Xq28: Report of the first familial case. Cytogenet Cell Genet 1999, 85:310.
160. Laporte J, Kioschis P, Hu LJ, et al. Cloning and characterization of an alternatively spliced gene in proximal Xq28 deleted in two patients with intersexual genitalia and myotubular myopathy. Genomics 1997, 41:458.
161. Fukami M, Wada Y, Miyabayashi K, Nishino I, Hasegawa T, Nordenskjold A, et al. CXorf6 is a causative gene for hypospadias. Nature Genetics 2006, 38:1369.
162. Wilkie AOM, Zeitlin HC, Lindenbaum RH, et al. Clinical features and molecular analysis of the b-thalassemia/mental retardation syndromes. II. Cases without detectable abnormality of the b-globin complex. Am J Hum Genet 1990, 46:1127.
163. Reardon W, Gibbons RJ, Winter RM, et al. Male pseudohermaphroditism in sibs with the alpha-thalassemia/mental retardation (ATR-X) syndrome. Am J Med Genet 1995, 55:285.
164. McPherson EW, Clemens MM, Gibbons RJ, et al. X-linked alpha-thalassemia/mental retardation (ATR-X) syndrome: A new kindred with severe genital anomalies and mild hematologic expression. Am J Med Genet 1995, 55:302.
165. Tang P, Park DJ, Marshall Graves JA, Harley VR ATRX and sex differentiation. Trends Endocrinol Metab 2004, 15:339.
166. Gibbons RJ, Picketts DJ, Villard L, et al. Mutations in a putative global transcriptional regulator cause X-linked mental retardation with b-thalassemia (ATR-X syndrome). Cell 1995, 80:837.
167. Wada T, Kubota T, Fukushima Y, et al. Molecular genetic study of Japanese patients with X-linked alpha-thalassemia/mental retardation syndrome (ATR-X). Am J Med Genet 2000, 94:242.
168. Cardoso C, Timsit S, Villard L, et al. Specific interaction between the XNP/ATR-X gene product and the SET domain of the human EZH2 protein. Hum Mol Genet 1998, 7:679.
169. Gibbons RJ, McDowell TL, Raman S, et al. Mutations in ATRX, encoding a SWI/SNF-like protein, cause diverse changes in the pattern of DNA methylation. Nat Genet 2000, 24:368.
170. Picketts DJ, Higgs DR, Bachoo S, et al. ATRX encodes a novel member of the SNF2 family of proteins: Mutations point to a common mechanism underlying the ATR-X syndrome. Hum Molec Genet 1996, 5:1899.
171. Badens C, Lacoste C, Philip N, Martini N, Courrier S, Giuliano F, et al. Mutations in PHD-like domain of the ATRX gene correlate with severe psychomotor impairment and severe urogenital abnormalities in patients with ATRX syndrome. Clin Genet 2006, 70:57.
172. Gibbons RJ, Higgs DR Molecular-clinical spectrum of the ATR-X syndrome. Am J Med Genet 2000, 97:204.
173. Law H, Mushtaq I, Wingrove K, Malone M, Sebire NJ Histopathological features of testicular regression syndrome: Relation to patient age and implications for management. Fetal Pediatr Pathol 2006, 25:119.
174. Joss N, Briard ML Embryonic testicular regression syndrome: variable phenotypic expression in siblings. J Pediatr 1980, 97:200.
175. Vilain E, Le Merrer M, Lecointre C, et al. IMAGe, a new clinical association of intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies. J Clin Endocrinol Metab 1999, 84:4335.
176. Topf KF, Kletter GB, Kelch RP, et al. Autosomal dominant transmission of the Pallister-Hall syndrome. J Pediatr 1993, 123:943.
177. Lee PA, Migeon CJ, Brown TR, et al. Robinow's syndrome: Partial primary hypogonadism in pubertal boys with persistence of micropenis. Am J Dis Child 1982, 136:327.
178. Dobyns WB, Berry-Kravis E, Havernick NJ, et al. X-linked lissencephaly with absent corpus callosum and ambiguous genitalia. Am J Med Genet 1999, 86:331.
179. Ogata T, Matsuo N, Hiraoka N, et al. X-linked lissencephaly with ambiguous genitalia: Delineation of further case. Am J Med Genet 2000, 94:174.
180. Uyanik G, Aigner L, Martin P, Gross C, Neumann D, Marschner-Schafer H, et al. ARX mutations in X-linked lissencephaly with abnormal genitalia. Neurology 2003, 61:232.
181. Verkauskas G, Jaubert F, Lortat-Jacob S, Malan V, Thibaud E, Nihoul-Fekete C The long-term followup of 33 cases of true hermaphroditism: A 40-year experience with conservative gonadal surgery. J Urol 2007, 177:726.
182. Aleck KA, Argueso L, Stone J, et al. True hermaphroditism with partial duplication of chromosome 22 and without SRY. Am J Med Genet 1999, 85:2.
183. Jimenez AL, Kofman-Alfaro S, Berumen J, et al. Partially deleted SRY gene confined to testicular tissue in a 46,XX true hermaphrodite without SRY in leukocytic DNA. Am J Med Genet 2000, 93:417.
184. Kuhnle U, Schwarz HP, Lohrs U, et al. Familial true hermaphroditism: paternal and maternal transmission of true hermaphroditism (46,XX) and XX maleness in the absence of Y-chromosomal sequences. Hum Genet 1993, 92:571.
185. Ramos ES, Moreira-Filho CA, Vicente YA, et al. SRY-negative true hermaphrodites and an XX male in two generations of the same family. Hum Genet 1996, 97:596-598.
186. Sarafoglou K, Ostrer H Familial sex reversal: A review. J Clin Endocrinol Metab 2000, 85:483-493.
187. Alonso G, Pasqualini T, Busaniche J, Ruiz E, Chemes H True hermaphroditism in a phenotypic male without ambiguous genitalia: An unusual presentation at puberty. Horm Res 2007, 68:261.
188. Ouhilal S, Turco J, Nangia A, Stotland M, Manganiello PD True hermaphroditism presenting as bilateral gynecomastia in an adolescent phenotypic male. Fertil Steril 2005, 83:1041.
189. Talerman A, Verp MS, Senekjian E, Gilewski T, Vogelzang N True hermaphrodite with bilateral ovotestes, bilateral gonadoblastomas and dysgerminomas, 46,XX/46,XY karyotype, and a successful pregnancy. Cancer 1990, 66:2668.
190. Minowada S, Fukutani K, Hara M, Shinohara M, Kamioka J, Isurugi K, et al. Childbirth in true hermaphrodite. Eur Urol 1984, 10:414.
191. Starceski PJ, Sieber WK, Lee PA Fertility in true hermaphroditism. Adol Pediatr Gynecol 1988, 1:55.
192. de la Chapelle A, Hastbacka J, Korhonen T, Maenpaa J The etiology of XX sex reversal. Reprod Nutr Dev 1990, 1:39S.
193. Kadandale JS, Wachtel SS, Tunca Y, et al. Localization of SRY by primed in situ labeling in XX and XY sex reversal. Am J Med Genet 2000, 95:71.
194. Dauwerse JG, Hansson KB, Brouwers AA, Peters DJ, Breuning MH An XX male with the sex-determining region Y gene inserted in the long arm of chromosome 16. Fertil Steril 2006, 86:463.e1.
195. Rajender S, Rajani V, Gupta NJ, Chakravarty B, Singh L, Thangaraj K SRY-negative 46,XX male with normal genitals, complete masculinization and infertility. Mol Hum Reprod 2006, 12:341.
196. Uhlenhaut NH, Treier M Foxl2 function in ovarian development. Mol Genet Metab 2006, 88:225.
197. Vaiman D, Koutita O, Oustry A, Elsen JM, Manfredi E, Fellous M, et al. Genetic mapping of the autosomal region involved in XX sex-reversal and horn development in goats, Mamm. Genome 1996, 7:133-137.
198. Achermann JC, Ito M, Ito M, et al. A mutation in the gene encoding steroidogenic factor-1 causes XY sex reversal and adrenal failure in humans. (Letter). Nature Genet 1999, 22:125.
199. Biason-Lauber A, Schoenle EJ Apparently normal ovarian differentiation in a prepubertal girl with transcriptionally inactive steroidogenic factor 1 (NR5A1/SF-1) and adrenocortical insufficiency. Am J Hum Genet 2000, 67:1563.
200. Lin L, Philibert P, Ferraz-de-Souza B, Kelberman D, Homfray T, Albanese A, et al. Heterozygous missense mutations in steroidogenic factor 1 (SF1/Ad4BP/NR5A1) are associated with 46,XY disorders of sex development with normal adrenal function. J Clin Endocrinol Metab 2007, 92:991.
201. Kremer H, Kraaij R, Toledo SPA, et al. Male pseudohermaphroditism due to a homozygous missense mutation of the luteinizing hormone receptor gene. Nat Genet 1995, 9:160.
202. Laue LL, Wu SM, Kudo M, et al. Compound heterozygous mutations of the luteinizing hormone receptor gene in Leydig cell hypoplasia. Mol Endocrinol 1996, 10:987.
203. Wu SM, Hallermeier KM, Laue L, et al. Inactivation of the luteinizing hormone/chorionic gonadotropin receptor by an insertional mutation in Leydig cell hypoplasia. Mol Endocrinol 1998, 12:1651.
204. Rousseau-Merck MF, Misrahi M, Atger M, et al. Localization of the human luteinizing hormone/chorion gonadotropin receptor gene (LHCGR) to chromosome 2p21. Cytogenet Cell Genet 1990, 54:77.
205. Misrahi M, Meduri G, Pissard S, et al. Comparison of immunocytochemical and molecular features with the phenotype in a case of incomplete male pseudohermaphroditism associated with a mutation of the luteinizing hormone receptor. J Clin Endocrinol Metab 1997, 82:2159.
206. Toldeo SPA, Brunner HG, Kraaij R, et al. An inactivation mutation of the luteinizing hormone receptor causes amenorrhea in a 46,XX female. J Clin Endocrinol Metab 1996, 81:3850.
207. Arnhold IJP, Latronico AC, Batista MC, et al. Ovarian resistance to luteinizing hormone: A novel cause of amenorrhea and infertility. Fertil Steril 1997, 67:394.
208. Richter-Unruh A, Korsch E, Hiort O, Holterhus PM, Themmen AP, Wudy SA Novel insertion frameshift mutation of the LH receptor gene: problematic clinical distinction of Leydig cell hypoplasia from enzyme defects primarily affecting testosterone biosynthesis. Eur J Endocrinol 2005, 152:255.
209. Dallaire L Syndrome of retardation with urogenital and skeletal anomalies (Smith-Lemli-Opitz syndrome): Clinical features and mode of inheritance. J Med Genet 1969, 6:113.
210. Moebius FF, Fitzky BU, Lee JN, et al. Molecular cloning and expression of the human delta7-sterol reductase. Proc Natl Acad Sci 1998, 95:1899.
211. Wassif CA, Maslen C, Kachilele-Linjewile S, et al. Mutations in the human sterol delta7-reductase gene at 11q12-13 cause Smith-Lemli-Opitz syndrome. Am J Hum Genet 1998, 63:55.
212. Witsch-Baumgartner M, Clayton P, Clusellas N, Haas D, Kelley RI, Krajewska-Walasek M, et al. Identification of 14 novel mutations in DHCR7 causing the Smith-Lemli-Opitz syndrome and delineation of the DHCR7 mutational spectra in Spain and Italy. Hum Mutat 2005, 25:412.
213. Engelking LJ, Evers BM, Richardson JA, Goldstein JL, Brown MS, Liang G Severe facial clefting in Insig-deficient mouse embryos caused by sterol accumulation and reversed by lovastatin. J Clin Invest 2006, 116:2356.
214. Porter FD Cholesterol precursors and facial clefting. J Clin Invest 1995, 116:2322.
215. Dallaire L, Mitchell G, Giguere R, et al. Prenatal diagnosis of Smith-Lemli-Opitz syndrome is possible by measurement of 7-dehydrocholesterol in amniotic fluid. Prenatal Diag 1995, 15:855.
216. Shackleton CHL, Roitman E, Kratz LE, et al. Equine type estrogens produced by a pregnant woman carrying a Smith-Lemli-Opitz fetus. J Clin Endocrinol Metab 1999, 84:1157.
217. Tint GS, Irons M, Elias ER, et al. Defective cholesterol biosynthesis associated with the Smith Lemli-Opitz syndrome. N Engl J Med 1994, 330:107.
218. Nowaczyk MJ, Waye JS, Douketis JD DHCR7 mutation carrier rates and prevalence of the RSH/Smith-Lemli-Opitz syndrome: Where are the patients?. Am J Med Genet A 2006, 140:2057.
219. Baker BY, Lin L, Kim CJ, Raza J, Smith CP, Miller WL, et al. Nonclassic congenital lipoid adrenal hyperplasia: A new disorder of the steroidogenic acute regulatory protein with very late presentation and normal male genitalia. J Clin Endocrinol Metab 2006, 91:4781.
220. Lin D, Sugawara T, Strauss JF, et al. Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis. Science 1995, 267:1828.
221. Tee MK, Lin D, Sugawara T, et al. TbA transversion 11 bp from a splice acceptor site in the gene for steroidogenic acute regulatory protein causes congenital lipoid adrenal hyperplasia. Hum Mol Genet 1995, 4:2299.
222. Nakae J, Tajima T, Sugawara T, et al. Analysis of the steroidogenic acute regulatory protein (StAR) gene in Japanese patients with congenital lipoid adrenal hyperplasia. Hum Mol Genet 1997, 6:571.
223. Bose HS, Sato S, Aisenberg J, et al. Mutations in the steroidogenic acute regulatory protein (StAR) in six patients with congenital lipoid adrenal hyperplasia. J Clin Endocrinol Metab 2000, 85:3636.
224. Clark BJ, Wells J, King SR, et al. The purification, cloning, and expression of a novel luteinizing hormone-induced mitochondrial protein in MA-10 mouse Leydig tumor cells. Characterization of the steroidogenic acute regulatory protein (StAR). J Biol Chem 1994, 269:28314.
225. Kallen CB, Arakane F, Christenson LK, et al. Unveiling the mechanism of action and regulation of the steroidogenic acute regulatory protein. Mol Cell Endocrinol 1998, 145:39.
226. Miller WL StAR search: What we know about how the steroidogenic acute regulatory protein mediates mitochondrial cholesterol import. Mol Endocrinol 2007, 21:589.
227. Bose HS, Sugawara T, Strauss JF, et al. The pathophysiology and genetics of congenital lipoid adrenal hyperplasia. N Engl J Med 1996, 335:1870.
228. Ogata T, Matsuo N, Saito M, et al. The testicular lesion and sexual differentiation in congenital lipoid adrenal hyperplasia. Helv Paediat Acta 1988, 43:531.
229. Bose HS, Pescovitz OH, Miller WL Spontaneous feminization in a 46,XX female patient with congenital lipoid adrenal hyperplasia caused by a homozygous frame shift mutation in the steroidogenic acute regulatory protein. J Clin Endocrinol Metab 1997, 82:1511.
230. Katsumata N, Ohtake M, Hojo T, Ogawa E, Hara T, Sato N, et al. Compound heterozygous mutations in the cholesterol side-chain cleavage enzyme gene (CYP11A) cause congenital adrenal insufficiency in humans. J Clin Endocrinol Metab 2002, 87:3808.
231. Hiort O, Holterhus PM, Werner R, Marschke C, Hoppe U, Partsch CJ, et al. Homozygous disruption of P450 side-chain cleavage (CYP11A1) is associated with prematurity, complete 46,XY sex reversal, and severe adrenal failure. J Clin Endocrinol Metab 2005, 90:538.
232. al Kandari H, Katsumata N, Alexander S, Rasoul MA Homozygous mutation of P450 side-chain cleavage enzyme gene (CYP11A1) in 46, XY patient with adrenal insufficiency, complete sex reversal, and agenesis of corpus callosum. J Clin Endocrinol Metab 2006, 91:2821.
233. Carroll MC, Campbell RD, Porter RR Mapping of steroid 21-hydroxylase genes adjacent to complement component C4 genes in HLA, the major histocompatibility complex in man. Proc Natl Acad Sci 1985, 82:521.
234. Higashi Y, Yoshioka H, Yamane M, et al. Complete nucleotide sequence of two steroid 21-hydroxylase genes tandemly arranged in human chromosome: a pseudogene and a genuine gene. Proc Natl Acad Sci 1986, 83:2841.
235. White PC, New MI, Dupont B Structure of human steroid 21-hydroxylase genes. Proc Natl Acad Sci 1986, 83:5111.
236. Rodrigues NR, Dunham I, Yu CY, et al. Molecular characterization of the HLA-lined steroid 21-hydroxylase B gene from an individual with congenital adrenal hyperplasia. EMBO J 1987, 6:1653.
237. Speiser PW, White PC Congenital adrenal hyperplasia. N Engl J Med 2003, 349:776.
238. Speiser PW, Dupont B, Rubinstein P, et al. High frequency of nonclassical steroid 21-hydroxylase deficiency. Am J Hum Genet 1985, 37:650.
239. Pang S, Clark A Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: newborn screening and its relationship to the diagnosis and treatment of the disorder. Screening 1993, 2:105.
240. Auchus RJ The backdoor pathway to dihydrotestosterone. Trends Endocrinol Metab 2004, 15:432.
241. Hanley NA, Arlt W The human fetal adrenal cortex and the window of sexual differentiation. Trends Endocrinol Metab 2006, 17:391.
242. Prader A Der genitalbefund beim ppseudohermaphroditismus femininus der kengenitalen adrenogenitalen syndroms. Helv Paediatr Acta 1954, 9:231.
243. Grumbach MM, Ducharme JR The effects of androgens on fetal sexual development: Androgen-induced female pseudohermaphroditism. Fertil Steril 1960, 11:157.
244. Witchel SF, Nayak S, Suda-Hartman M, et al. Newborn screening for 21-hydroxylase deficiency: Results of CYP21 molecular genetic analysis. J Pediatr 1997, 131:328.
245. Gourmelen M, Gueux B, Pham HTM, et al. Detection of heterozygous carriers for 21-hydroxylase deficiency by plasma 21-deoxycortisol measurement. Acta Endocrinol 1987, 12:525.
246. Fiet J, Grueux B, Gourmelen M, et al. Comparison of basal and drenocorticotropin-stimulated plasma 21-deoxycortisol and 17-hydroxyprogesterone values as biological markers of late-onset adrenal hyperplasia. J Clin Endocrinol Metab 1988, 66:659.
247. Votava F, Torok D, Kovacs J, Moslinger D, Baumgartner-Parzer SM, the Middle European Society for Paediatric Endocrinology, et al. Congenital Adrenal Hyperplasia (MESPE-CAH) Study Group: Estimation of the false-negative rate in newborn screening for congenital adrenal hyperplasia. Eur J Endocrinol 2005, 152:869.
248. Bristow J, Tee MK, Gitelman SE, et al. Tenascin-X: a novel extracellular matrix protein encoded by the human XB gene overlapping P450c21B. J Cell Biol 1993, 122:265.
249. Wedell A, Thilén A, Ritzén EM, et al. Mutational spectrum of the steroid 21-hydroxylase gene in Sweden: Implications for genetic diagnosis and association with disease manifestation. J Clin Endocrinol Metab 1994, 78:1145.
250. Ferenczi A, Garami M, Kiss E, et al. Screening for mutations of 21-hydroxylase gene in Hungarian patients with congenital adrenal hyperplasia. J Clin Endocrinol Metab 1999, 84:2369.
251. Wilson RC, Nimkarn S, Dumic M, Obeid J, Azar M, Najmabadi H, et al. Ethnic-specific distribution of mutations in 716 patients with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. Mol Genet Metab 2007, 90:414.
252. Nordenström, Thilén A, Hagenfeldt L, et al. Genotyping is a valuable diagnostic complement to neonatal screening for congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency. J Clin Endocrinol Metab 1999, 84:1505.
253. Fitness J, Dixit N, Webster D, et al. Genotyping of CYP21, linked chromosome 6p markers, and a sex-specific gene in neonatal screening for congenital adrenal hyperplasia. J Clin Endocrinol Metab 1999, 84:960.
254. Wedell A, Chun X, Luthman H A steroid 21-hydroxylase allele concomitantly carrying four disease-causing mutations is not uncommon in the Swedish population. Hum Genet 1994, 93:204.
255. Witchel SF, Lee PA, Trucco M Who is a carrier? Detection of unsuspected mutations in 21-hydroxylase deficiency. Am J Med Genet 1996, 61:2.
256. Witchel SF, Smith R, Crivellaro CE, et al. CYP21 mutations in Brazilian patients with 21-hydroxylase deficiency. Hum Genet 2000, 106:414.
257. Rösler A, Lieberman E, Cohen T High frequency of congenital adrenal hyperplasia (classic 11β-hydroxylase deficiency) among Jews from Morocco. Am J Med Genet 1992, 42:827.
258. Rösler A, Cohen H Absence of steroid biosynthetic detects in heterozygote individuals for classic 11β-hydroxylase deficiency due to a R448H mutation in the CYP11B1 gene. J Clin Endocrinol Metab 1995, 80:3771.
259. Peter M, Sippell WG Evidence for endocrinological abnormalities in heterozygotes for adrenal 11β-hydroxylase deficiency of a family with the R448H mutation in the CYP11B1 gene. J Clin Endocrinol Metab 1997, 82:3506.
260. Merke DP, Tajima T, Chhabra A, et al. Novel CYP11B1 mutations in congenital adrenal hyperplasia due to steroid 11β-hydroxylase deficiency. J Clin Endocrinol Metab 1998, 83:270.
261. Curnow KM, Slutsker L, Vitek J, et al. Mutations in the CYP11B1 gene causing congenital adrenal hyperplasia and hypertension cluster in exons 6, 7, and 8. Proc Natl Acad Sci USA 1993, 90:4552.
262. White PC, Dupont J, New MI, et al. A mutation CYP11B1 (Arg448(His) associated with steroid 11-hydroxylase deficiency in Jews of Moroccan origin. J Clin Invest 1991, 87:1664.
263. Mornet E, Dupont J, Vitek A, et al. Characterization of two genes encoding human steroid 11β-hydroxylase(P-45011B). J Biol Chem 1989, 35:20961.
264. White PC Steroid 11 beta-hydroxylase deficiency and related disorders. Endocrinol Metab Clin North Am 2001, 30:61.
265. Simard J, Ricketts ML, Gingras S, Soucy P, Feltus FA, Melner MH Molecular biology of the 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase gene family. Endocr Rev 2005, 26:525.
266. Luu-The V, Lachance Y, Labrie C, et al. Full length cDNA structure and deduced amino acid sequence of human 3β-hydroxy-5-ene steroid dehydrogenase. Mol Endocrinol 1989, 3:1310.
267. Rhéaume E, Lachance Y, Zhao HF, et al. Structure and expression of a new cDNA encoding the almost exclusive 3β-hydroxysteroid dehydrogenase/(5-ene isomerase in human adrenals and gonads. Mol Endocrinol 1991, 5:1147.
268. Rhéaume E, Simard J, Morel Y, et al. Congenital adrenal hyperplasia due to point mutations in the type II 3β-hydroxysteroid dehydrogenase gene. Nat Genet 1992, 1:239.
269. Simard J, Rhéaume E, Sanchez R, et al. Molecular basis of congenital adrenal hyperplasia due to 3β-hydroxysteroid dehydrogenase deficiency. Mol Endocrinol 1993, 7:716.
270. Moisan AM, Ricketts ML, Tardy V, et al. New insight into the molecular basis of 3β-hydroxysteroid dehydrogenase deficiency: identification of eight mutations in the HSD3B2 gene in eleven patients from seven new families and comparison of the functional properties of twenty-five mutant enzymes. J Clin Endocrinol Metab 1999, 84:4410.
271. Gendrel D, Chaussain JL, Roger M, et al. Congenital adrenal hyperplasia due to blockade of 3β-hydroxysteroid dehydrogenase. Arch Fr Pédiatr 1979, 36:647.
272. Saez JM, De Peretti E, Morera AM, et al. Familial male pseudohermaphroditism with gynecomastia due to a testicular 17-ketosteroid reductase defect. I. Study in vivo. J Clin Endocr 1971, 32:604.
273. Boehmer ALM, Brinkmann AO, Sandkuijl LA, et al. 17β-hydroxysteroid dehydrogenase 3 deficiency: diagnosis, phenotypic variability, population genetics, and worldwide distribution of ancient and de novo mutations. J Clin Endocrinol Metab 1999, 84:4713.
274. Andersson S, Geissler WM, Wu L, et al. Molecular genetics and pathophysiology of 17-beta-hydroxysteroid dehydrogenase 3 deficiency. J Clin Endocr Metab 1996, 81:130.
275. Geissler WM, Davis DL, Wu L, et al. Male pseudohermaphroditism caused by mutations of testicular 17-beta-hydroxysteroid dehydrogenase 3. Nature Genet 1994, 7:34.
276. Lee YS, Kirk JM, Stanhope RG, Johnston DI, Harland S, Auchus RJ, et al. Phenotypic variability in 17beta-hydroxysteroid dehydrogenase-3 deficiency and diagnostic pitfalls. Clin Endocrinol (Oxford) 2007, [E-pub ahead of print].
277. Andersson S, Russell DW, Wilson JD 17β-hydroxysteroid dehydrogenase 3 deficiency. Trends Endocrinol Metab 1996, 7:121.
278. Gross DJ, Landau H, Kohn G, et al. Male pseudohermaphroditism due to 17β-hydroxysteroid dehydrogenase deficiency: Gender reassignment in early infancy. Acta Endocrinol 1986, 112:238.
279. Rösler A, Silverstein S, Abeliovich D A (R80Q) mutation in 17β-hydroxysteroid dehydrogenase type 3 gene among Arabs of Israel is associated with pseudohermaphroditism in males and normal asymptomatic females. J Clin Endocrinol Metab 1996, 81:1827.
280. Mendonça BB, Arnhold IJ, Bloise W, et al. 17β-hydroxysteroid dehydrogenase 3 deficiency in women. J Clin Endocrinol Metab 1999, 84:802.
281. Katz MD, Kligman I, Cai L-Q, et al. Paternity in intrauterine insemination with sperm from a man with 5-alpha-reductase-2 deficiency. New Eng J Med 1997, 336:994.
282. Andersson S, Berman DM, Jenkins EP, et al. Deletion of steroid 5-alpha-reductase gene in male pseudohermaphroditism. Nature 1991, 354:159.
283. Hochberg Z, Chayen R, Reiss N, et al. Clinical, biochemical, and genetic findings in a large pedigree of male and female patients with 5-alpha-reductase 2 deficiency. J Clin Endocr Metab 1996, 81:2821.
284. Peterson RE, Imperato-McGinley J, Gautier T, Shackleton C Male pseudohermaphroditism due to multiple defects in steroid-biosynthetic microsomal mixed-function oxidases: A new variant of congenital adrenal hyperplasia. N Engl J Med 1985, 313:1182.
285. Shackleton C, Marcos J, Arlt W, Hauffa BP Prenatal diagnosis of P450 oxidoreductase deficiency (ORD): A disorder causing low pregnancy estriol, maternal and fetal virilization, and the Antley-Bixler syndrome phenotype. Am J Med Genet A 2004, 129:105.
286. Arlt W, Walker EA, Draper N, Ivison HE, Ride JP, Hammer F, et al. Congenital adrenal hyperplasia caused by mutant P450 oxidoreductase and human androgen synthesis: analytical study. Lancet 2004, 363:2128.
287. Fluck CE, Tajima T, Pandey AV, Arlt W, Okuhara K, Verge CF, et al. Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome. Nat Genet 2004, 36:228.
288. Huang N, Pandey AV, Agrawal V, Reardon W, Lapunzina PD, Mowat D, et al. Diversity and function of mutations in p450 oxidoreductase in patients with Antley-Bixler syndrome and disordered steroidogenesis. Am J Hum Genet 2005, 76:729.
289. Krone N, Dhir V, Ivison HE, Arlt W Congenital adrenal hyperplasia and P450 oxidoreductase deficiency. Clin Endocrinol (Oxford) 2007, 66:162.
290. Wilson JD, Auchus RJ, Leihy MW, Guryev OL, Estabrook RW, Osborn SM, et al. 5alpha-androstane-3alpha, 17beta-diol is formed in tammar wallaby pouch young testes by a pathway involving 5alpha-pregnane-3alpha, 17alpha-diol-20-one as a key intermediate. Endocrinology 2003, 144:575.
291. Shozu M, Akasofu K, Harada T, et al. A new cause of female pseudohermaphroditism: Placental aromatase deficiency. J Clin Endocrinol Metab 1991, 72:560.
292. Harada N, Ogawa H, Shozu M, et al. Genetic studies to characterize the origin of the mutation in placental aromatase deficiency. Am J Hum Genet 1992, 51:666.
293. Mullis PE, Yoshimura N, Kuhlmann B, et al. Aromatase deficiency in a female who is compound heterozygote for two new point mutations in the P450(arom) gene: Impact of estrogens on hypergonadotropic hypogonadism, multicystic ovaries, and bone densitometry in childhood. J Clin Endocr Metab 1997, 82:1739.
294. Ludwig M, Beck A, Wickert L, et al. Female pseudohermaphroditism associated with a novel homozygous G-to-A (V370-to-M) substitution in the P-450 aromatase gene. J Pediatr Endocrinol Metab 1998, 11:657.
295. Morishima A, Grumbach MM, Simpson ER, et al. Aromatase deficiency is male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab 1995, 80:3689.
296. Jones ME, Boon WC, McInnes K, Maffei L, Carani C, Simpson ER Recognizing rare disorders: aromatase deficiency. Nat Clin Pract Endocrinol Metab 2007, 3:414.
297. Lin L, Ercan O, Raza J, Burren CP, Creighton SM, Auchus RJ, et al. Variable phenotypes associated with aromatase (CYP19) insufficiency in humans. J Clin Endocrinol Metab 2007, 92:982.
298. Chen S, Besman MJ, Sparkes RS, et al. Human aromatase: cDNA cloning, Southern blot analysis, and assignment of the gene to chromosome 15. DNA 1988, 7:27.
299. Lin L, Ercan O, Raza J, Burren CP, Creighton SM, Auchus RJ, et al. Variable phenotypes associated with aromatase (CYP19) insufficiency in humans. J Clin Endocrinol Metab 2007, 92:982.
300. Bulun SE Aromatase deficiency in women and men: would you have predicted the phenotypes?. J Clin Endocr Metab 1996, 81:867.
301. Jones ME, Boon WC, Proietto J, Simpson ER Of mice and men: The evolving phenotype of aromatase deficiency. Trends Endocrinol Metab 2006, 17:55.
302. Vinggaard AM, Hnida C, Breinholt V, et al. Screening of selected pesticides for inhibition of CYP19 aromatase activity in vitro. Toxicol In Vitro 2000, 14:227.
303. Paris F, Jeandel C, Servant N, Sultan C Increased serum estrogenic bioactivity in three male newborns with ambiguous genitalia: A potential consequence of prenatal exposure to environmental endocrine disruptors. Environ Res 2006, 100:39.
304. Stillman RJ In vitro exposure to diethylstilbestrol: Adverse effects on the reproductive tract and reproductive performance in male and female offspring. Am J Obstet Gynecol 1982, 142:905.
305. Toppari J, Skakkebaek NE Sexual differentiation and environmental endocrine disrupters. Bailliere Clin Endocrinol Metab 1998, 12:143.
306. Ministry of Environment and Energy, Denmark Male reproductive health and environmental chemicals with estrogenic effects 1995, Danish Environmental Protection Agency, Copenhagen, Miljoprojekt No 290.
307. Sharpe RM Another DDT connection. Nature 1995, 375:538.
308. Weidner IS, Moller H, Jensen TK, et al. Cryptorchidism and hypospadias in sons of gardeners and farmers. Environ Health Perspect 1998, 106:793.
309. Kester MHA, Bulduk S, Tibboel D, et al. Potent inhibition of estrogen sulfotransferase by hydroxylated PCB metabolites: a novel pathway explaining the estrogenic activity of PCBs. Endocrinol 2000, 141:1897.
310. Hughes IA, Deeb A Androgen resistance. Best Pract Res Clin Endocrinol Metab 2006, 20:577.
311. Migeon BR, Brown TR, Axelman J, et al. Studies of the locus for androgen receptor: Localization on the human X chromosome and evidence for homology with the Tfm locus in the mouse. Proc Natl Acad Sci USA 1981, 78:6339.
312. Brown CJ, Goss SJ, Lubahn DB, et al. Androgen receptor locus on the human X chromosome: Regional localization to Xq11-12 and description of a DNA polymorphism. Am J Hum Genet 1989, 44:264.
313. Hiort O, Sinnecker GH, Holterhus PM, Nitsche EM, Kruse K Inherited and de novo androgen receptor gene mutations: Investigation of single-case families. J Pediatr 1998, 132:939.
314. Kohler B, Lumbroso S, Leger J, Audran F, Grau ES, Kurtz F, et al. Androgen insensitivity syndrome: Somatic mosaicism of the androgen receptor in seven families and consequences for sex assignment and genetic counseling. J Clin Endocrinol Metab 2005, 90:106.
315. Deeb A, Hughes IA Inguinal hernia in female infants: A cue to check the sex chromosomes. BJU International 2005, 96:401.
316. Bouvattier C, Carel JC, Lecointre C, David A, Sultan C, Bertrand AM, et al. Postnatal changes of T, LH, and FSH in 46,XY infants with mutations in the AR gene. J Clin Endocrinol Metab 2002, 87:29.
317. Quigley CA The postnatal gonadotropin and sex steroid surge-insights from the androgen insensitivity syndrome. J Clin Endocrinol Metab 2002, 87:24.
318. Hannema SE, Scott IS, Rajpert-De Meyts E, Skakkebaek NE, Coleman N, Hughes IA Testicular development in the complete androgen insensitivity syndrome. J Pathol 2006, 208:518.
319. Brinkman AO, Faber PW, van Rooy HCJ, et al. The human androgen receptor: Domain structure, genomic organization and regulation of expression. J Steroid Biochem Molec Biol 1989, 34:307-310.
320. Lumbroso R, Beitel LK, Vasiliou DM, et al. Codon-usage variants in the polymorphic (GGN)n trinucleotide repeat of the human androgen receptor gene. Hum Genet 1997, 101:43.
321. Tut TG, Ghadessy FJ, Trifiro MA, et al. Long polyglutamine tracts in the androgen receptor are associated with reduced trans-activation, impaired sperm production, and male infertility. J Clin Endocr Metab 1997, 82:3777.
322. Dowsing AT, Yong EL, Clark M, et al. Linkage between male infertility and trinucleotide repeat expansion in the androgen-receptor gene. Lancet 1999, 354:640.
323. Lim HN, Chen H, McBride S, et al. Longer polyglutamine tracts in the androgen receptor are associated with moderate to severe undermasculinized genitalia in XY males. Hum Molec Genet 2000, 9:829.
324. Beilin J, Ball EM, Favaloro JM, et al. Effect of the androgen receptor CAG repeat polymorphism on transcriptional activity: Specificity in prostate and non-prostate cell lines. J Mol Endocrinol 2000, 25:85-96.
325. Lee DK, Chang C Endocrine mechanisms of disease: Expression and degradation of androgen receptor, mechanism and clinical implication. J Clin Endocrinol Metab 2003, 88:4043.
326. Poukka H, Karvonen U, Janne OA, Palvimo JJ Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1). Proc Natl Acad Sci USA 2000, 97:14145.
327. Faus H, Haendler B Post-translational modifications of steroid receptors. Biomed Pharmacother 2006, 60:520.
328. Elhaji YA, Stoica I, Dennis S, Purisima EO, Trifiro MA Impaired helix 12 dynamics due to proline 892 substitutions in the androgen receptor are associated with complete androgen insensitivity. Hum Mol Genet 2006, 15:921.
329. Wong CI, Zhou ZX, Sar M, Wilson EM Steroid requirement for androgen receptor dimerization and DNA binding. Modulation by intramolecular interactions between the NH2-terminal and steroid binding domains. J Biol Chem 1993, 268:19004.
330. He B, Gampe RT, Kole AJ, Hnat AT, Stanley TB, An G Structural basis for androgen receptor interdomain and coactivator interactions suggests a transition in nuclear receptor activation function dominance. Mol Cell 2004, 16:425.
331. Kemppainen JA, Lane MV, Sar M, et al. Androgen receptor phosphorylation, turnover, nuclear transport, and transcriptional activation. Specificity for steroids and antihormones. J Biol Chem 1992, 267:968.
332. Schoenmakers E, Verrijdt G, Peeters B, et al. Differences in DNA binding characteristics of the androgen and glucocorticoid receptors can determine hormone-specific responses. J Biol Chem 2000, 275:12290.
333. Quigley CA, Friedman KJ, Johnson A, et al. Complete deletion of the androgen receptor gene: Definition of the null phenotype of the androgen insensitivity syndrome and determination of carrier status. J Clin Endocr Metab 1992, 74:927.
334. McPhaul MJ, Griffin JE Male pseudohermaphroditism caused by mutations of the human androgen receptor. J Clin Endocrinol Metab 1999, 84:3435.
335. Rodien P, Mebarki F, Moszowicz I, et al. Different phenotypes in a family with androgen insensitivity caused by the same M708I point mutation in the androgen receptor gene. J Clin Endocrinol Metab 1996, 81:2994.
336. Elhaji YA, Wu JH, Gottlieb B, Beitel LK, Alvarado C, Batist G An examination of how different mutations at arginine 855 of the androgen receptor result in different androgen insensitivity phenotypes. Mol Endocrinol 2004, 18:1876.
337. Kazemi-Esfarjani P, Beitel LK, Trifiro M, et al. Substitution of valine-865 by methionine or leucine in the human androgen receptor causes complete or partial androgen insensitivity, respectively with distinct androgen receptor phenotypes. Mol Endocrinol 1993, 7:37.
338. Holterhus P-M, Sinnecker GHG, Hiort O Phenotypic diversity and testosterone-induced normalization of mutant L712F androgen receptor function in a kindred with androgen insensitivity. J Clin Endocrinol Metab 2000, 85:3245.
339. La Spada AR, Wilson EM, Lubahn DB, et al. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 1991, 352:77.
340. Katsuno M, Adachi H, Kume A, Li M, Nakagomi Y, Niwa H, et al. Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Neuron 2002, 35:843.
341. Choong CS, Kemppainen JA, Zhou ZX, et al. Reduced androgen receptor gene expression with first exon CAG repeat expansion. Molec Endocr 1996, 10:1527.
342. Hutson JM, Davidson PM, Reece L, Baker ML, Zhou B Failure of gubernacular development in the persistent Mullerian duct syndrome allows herniation of the testes. Pediatr Surg Int 1994, 9:544.
343. Josso N, Belville C, di Clemente N, Picard JY AMH and AMH receptor defects in persistent Mullerian duct syndrome. Hum Reprod Update 2005, 11:351.
344. Li S, Qayyum A, Coakley FV, Hricak H Association of renal agenesis and mullerian duct anomalies. J Comput Assist Tomogr 2000, 24:829.
345. Duncan PA, Shapiro LR, Stangel JJ, et al. The MURCS association: Müllerian duct aplasia, renal duct aplasia, and cervicothoracic somite dysplasia. J Pediatr 1979, 95:399.
346. Wulfsberg EA, Grigsby TM Rokitansky sequence in association with the facio-auriculo-vertebral sequence: Part of a mesodermal malformation spectrum?. Am J Med Genet 1990, 37:100.
347. Chityat D, Hahm SYE, Marion RW, et al. Further delineation of the McKusick-Kaufman hydrometrocolpospolydactyly syndrome. Am J Dis Child 1987, 141:1133.
348. Oppelt P, von Have M, Paulsen M, Strissel PL, Strick R, Brucker S, et al. Female genital malformations and their associated abnormalities. Fertil Steril 2007, 87:335.
349. Caron P, Chauvin S, Christin-Maitre S, et al. Resistance of hypogonadic patients with mutated GnRH receptor genes to pulsatile GnRH administration. J Clin Endocrinol Metab 1999, 84:990.
350. Semple RK, Achermann JC, Ellery J, Farooqi IS, Karet FE, Stanhope RG, et al. Two novel missense mutations in g protein-coupled receptor 54 in a patient with hypogonadotropic hypogonadism. J Clin Endocrinol Metab 2005, 90:1849.
351. Schwanzel-Fukuda M, Pfaff DW The migration of luteinizing hormone-releasing hormone (LHRH) neurons from the medial olfactory placode into the medial basal forebrain. Experientiat 1990, 46:956.
352. Schwanzel-Fukuda M, Bick D, Pfaff DW Luteinizing hormone releasing hormone (LHRH)-expressing cells do not migrate normally in an inherited hypogonadal (Kallmann) syndrome. Mol Brain Res 1989, 6:311.
353. Bick DP, Ballabio A Bringing Kallmann syndrome into focus. Am J Neuroradiol 1993, 14:852.
354. Franco B, Guioli S, Pragliola A, et al. A gene deleted in Kallmann's syndrome shares homology with neural cell adhesion and axonal path-finding molecules. Nature 1991, 353:529.
355. Maya-Nuñez G, Zenteno JC, Ulloa-Aguirre A, et al. A recurrent missense mutation in the KAL gene in patients with X-linked Kallmann's syndrome. J Clin Endocrinol Metab 1998, 83:1650.
356. De Roux N, Young J, Brailly-Tabard S, et al. The same molecular defects of the gonadotropin releasing hormone receptor determine a variable degree of hypogonadism in affected kindred. J Clin Endocrinol Metab 1999, 84:567.
357. de Roux N, Genin E, Carel JC, Matsuda F, Chaussain JL, Milgrom E Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54. Proc Natl Acad Sci USA 2003, 100:10972.
358. Seminara SB, Messager S, Chatzidaki EE, Thresher RR, Acierno JS, Shagoury JK, et al. The GPR54 gene as a regulator of puberty. N Engl J Med 2003, 349:1614.
359. Dode C, Levilliers J, Dupont JM, De Paepe A, Le Du N, Soussi-Yanicostas N, et al. Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome. Nat Genet 2003, 33:463.
360. Dode C, Teixeira L, Levilliers J, Fouveaut C, Bouchard P, Kottler ML, et al. Kallmann syndrome: Mutations in the genes encoding prokineticin-2 and prokineticin receptor-2. PLoS Genet 2006, 2:e175.
361. Virtanen HE, Bjerknes R, Cortes D, Jorgensen N, Rajpert-De Meyts E, et al. Cryptorchidism: Classification, prevalence and long-term consequences. Acta Paediatr 2007, 96:611.
362. Virtanen HE, Tapanainen AE, Kaleva MM, Suomi AM, Main KM, Skakkebaek NE, et al. Mild gestational diabetes as a risk factor for congenital cryptorchidism. J Clin Endocrinol Metab 2006, 91:4862.
363. Virtanen HE, Cortes D, Rajpert-De Meyts E, Ritzen EM, Nordenskjold A, Skakkebaek NE, et al. Development and descent of the testis in relation to cryptorchidism. Acta Paediatr 2007, 96:622.
364. Tomboc M, Lee PA, Mitwally MF, et al. Insulin- like3/relaxin-like factor gene mutations are associated with cryptorchidism. J Clin Endocrinol Metab 2000, 85:4013.
365. Kolon TF, Wiener JS, Lewitton M, et al. Analysis of homeobox gene HOXA10 mutations in cryptorchidism. J Urol 1999, 161:275.
366. Scheffer IE, Hutson JM, Warne GL, et al. Extreme virilization in patients with congenital adrenal hyperplasia fails to induce descent of the ovary. Pediatr Surg Int 1988, 3:165.
367. Lee SMY, Hutson JM Effect of androgens on the cranial suspensory ligament and ovarian position. Anat Rec 1999, 255:306.
368. Cortes D, Thorup JM, Visfeldt J Cryptorchidism: Aspects of fertility and neoplasms. A study including data of 1,335 consecutive boys who underwent testicular biopsy simultaneously with surgery for cryptorchidism. Horm Res 2001, 55:21.
369. Huff DS, Fenig DM, Canning DA, Carr MG, Zderic SA, Snyder HM Abnormal germ cell development in cryptorchidism. Horm Res 2001, 55:11.
370. Callegari C, Everett S, Ross M, Brasel JA Anogenital ratio: Measure of fetal virilization in premature and full-term newborn infants. J Pediatr 1987, 111:240.
371. Rink RC, Adams MC, Misseri R A new classification for genital amniguity and urogenital sinus anomalies. BJU Inter 2005, 95:638-642.
372. Riley WJ, Rosenbloom AL Clitoral size in infancy. J Pediatr 1980, 96:918.
373. Kocova M, Siegel SF, Wenger SL, et al. Detection of Y chromosome sequences in a 45X/46XXq- patient by Southern blot analysis of PCR-amplified DNA and fluorescent in situ hybridization (FISH). Am J Med Genet 1995, 55:483.
374. Torresani T, Grüters A, Scherz R, et al. Improving the efficacy of newborn screening for congenital adrenal hyperplasia by adjusting the cut-off level of 17β-hydroxyprogesterone to gestational age. Screening 1994, 3:77.
375. Van der Kamp HJ, Wit JM Neonatal screening for congenital adrenal hyperplasia. Eur J Endocrinol 2004, 151:U71.
376. Lee MM, Donahoe PK, Hasegawa T, et al. Mullerian inhibiting substance in humans: Normal levels from infancy to adulthood. J Clin Endocrinol Metab 1996, 81:571.
377. Guibourdenche J, Lucidarme N, Chevenne D, Rigal O, Nicolas M, Luton D, et al. Anti-Mullerian hormone levels in serum from human foetuses and children: Pattern and clinical interest. Mol Cell Endocrinol 2003, 211:55.
378. Rey RA, Belville C, Nihoul-Fekete C, et al. Evaluation of gonadal function in 107 intersex patients by means of serum antimullerian hormone measurement. J Clin Endocrinol Metab 1999, 84:627.
379. Bergada I, Milani C, Bedecarras P, Andreone L, Ropelato MG, Gottlieb S, et al. Time course of the serum gonadotropin surge, inhibins, and anti-Mullerian hormone in normal newborn males during the first month of life. J Clin Endocrinol Metab 2006, 91:4092.
380. Ng KL, Ahmed SF, Hughes IA Pituitary-gonadal axis in male undermasculinization. Arch Dis Child 2000, 82:54-58.
381. Jurgensen M, Hampel E, Hiort O, Thyen U "Any decision is better than none" decision-making about sex of rearing for siblings with 17beta-hydroxysteroid-dehydrogenase-3 deficiency. Arch Sex Behav 2006, 35:359.
382. Lerman SE, McAleer IM, Kaplan GW Sex assignment in cases of ambiguous genitalia and its outcome. Urol 2000, 55:8.
383. Imperato-McGinley J, Miller M, Wilson JD, Peterson RE, Shackleton C, Gajdusek DC A cluster of male pseudohermaphrodites with 5 alpha-reductase deficiency in Papua New Guinea. Clin Endocrinol (Oxford) 2001, 34:293.
384. Cohen-Kettenis PT Gender change in 46,XY persons with 5alpha-reductase-2 deficiency and 17beta-hydroxysteroid dehydrogenase-3 deficiency. Arch Sex Behav 2005, 34:399.
385. Carani C, Granata AR, Rochira V, Caffagni G, Aranda C, Antunez P, et al. Sex steroids and sexual desire in a man with a novel mutation of aromatase gene and hypogonadism. Psychoneuroendocrinology 2005, 30:413.
386. Glassberg KI Gender assignment and the pediatric urologist. J Urol 1999, 161:1308.
387. Meyer-Bahlburg HF, Dolezal C, Baker SW, Carlson AD, Obeid JS, New MI Prenatal androgenization affects gender-related behavior but not gender identity in 5-12-year old girls with congenital adrenal hyperplasia. Arch Sex Behav 2004, 33:97.
388. Berenbaum SA, Bailey JM Effects on gender identity of prenatal androgens and genital appearance: Evidence from girls with congenital adrenal hyperplasia. J Clin Endocrinol Metab 2003, 88:1102.
389. Long DN, Wisniewski AB, Migeon CJ Gender role across development in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Pediatr Endocrinol Metab 2004, 17:1367.
390. Malouf MA, Migeon CJ, Carson KA, Petrucci L, Wisniewski AB Cognitive outcome in adult women affected by congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Horm Res 2006, 65:142.
391. Hines M, Brook C, Conway GS Androgen and psychosexual development: Core gender identity, sexual orientation and recalled childhood gender role behavior in women and men with congenital adrenal hyperplasia (CAH). J Sex Res 2004, 41:75.
392. Dittmmann RW, Kappes ME, Kappes MH Sexual behavior in adolescent and adult females with congenital adrenal hyperplasia. Psychoneuroendocrinology 1992, 17:153.
393. Zucker KJ, Bradley SJ, Oliver G, Blake J, Fleming S, Hood J Psychosexual development of women with congenital adrenal hyperplasia. Horm Behav 1996, 30:300.
394. Meyer-Bahlburg HF Gender and sexuality in classic congenital adrenal hyperplasia. Endocrinol Metab Clin North AM 2001, 30:155.
395. Wisniewski AB, Migeon CJ, Malouf MA, Geargart JP Psychosexual outcome in women affected by congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Urol 2004, 171:2497.
396. Meyer-Bahlberg HF, Dolezal C, Baker SW, Ehrhardt AA, New MI Gender development in women with congenital adrenal hyperplasia as a function of disorder severity. Arch Sex Behav 2006, 35:667.
397. Meyer-Bahlburg HF, Gruen RS, New MI, Bell JJ, Morishima A, Shimshi M, et al. Gender change from female to male in classical congenital adrenal hyperplasia. Horm Behav 1996, 30:319.
398. Berenbaum SA, Korman Bryk K, Duck SC, Resnick SM Psychological adjustment in children and adults with congenital adrenal hyperplasia. J Pediatr 2004, 144:741.
399. Berenbaum SA, Bailey JM Effects on gender identity of prenatal androgens and genital appearance: Evidence from girls with congenital adrenal hyperplasia. J Clin Endocrinol Metab 2003, 88:1102.
400. Dayner JE, Lee PA, Houk CP Medical treatment of intersex: parental perspectives. J Urol 2004, 172:1762.
401. Baskin LS, Erol A, Li YW, Liu WH, Kurzrocl E, Cunha GR Anatomical studies of the human clitoris. J Urol 1999, 162:1015.
402. Akman Y, Lui W, Li YW, Baskin LS Penile anatomy under the pubic arch: Reconstructive implications. J Urol 2001, 166:225.
403. Creighton SM, Minto CL, Steele SJ Objective cosmetic and anatomical outcomes at adolescence of feminising surgery for ambiguous genitalia done in childhood. Lancet 2001, 358:124.
404. Gollu G, Yildiz RV, Bingol-Kologlu M, Yagmurlu A, Senyucel MF, Aktug T, et al. Ambiguous genitalia: an overview of 17 years' experience. J Pediatr Surg 2007, 42:840.
405. Fallat ME, Donahoe PK Intersex genetic anomalies with malignant potential. Curr Opin Pediatr 2006, 18:305.
406. Cools M, van Aerde K, Kersemaekers AM, Boter M, Drop SL, Wolffenbuttel KP, et al. Morphological and immunohistochemical differences between gonadal maturation delay and early germ cell neoplasia in patients with undervirilization syndromes. J Clin Endocrinol Metab 2005, 90:5295.
407. Cools M, Drop SL, Wolffenbuttel KP, Oosterhuis JW, Looijenga LH Germ cell tumors in the intersex gonad: Old paths, new directions, moving frontiers. Endocr Rev 2006, 27:468.
408. Mazzanti L, Cicognani A, Baldazzi L, Bergamaschi R, Scarano E, Strocchi S, et al. Gonadoblastoma in Turner syndrome and Y-chromosome-derived material. Am J Med Genet A 2005, 135:150.
409. Ankarberg-Lindgren C, Elfving M, Wikland KA, Norjavaara E Nocturnal application of transdermal estradiol patches produces levels of estradiol that mimic those seen at the onset of spontaneous puberty in girls. J Clin Endocrinol Metab 2001, 86:3039.